14-23988987-C-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_198083.4(DHRS4L2):ā€‹c.40C>Gā€‹(p.Arg14Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000054 in 1,611,410 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00026 ( 0 hom., cov: 33)
Exomes š‘“: 0.000032 ( 2 hom. )

Consequence

DHRS4L2
NM_198083.4 missense

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.774
Variant links:
Genes affected
DHRS4L2 (HGNC:19731): (dehydrogenase/reductase 4 like 2) This gene encodes a member of the short chain dehydrogenase reductase family. The encoded protein may be an NADPH dependent retinol oxidoreductase. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018613487).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DHRS4L2NM_198083.4 linkuse as main transcriptc.40C>G p.Arg14Gly missense_variant 1/8 ENST00000335125.11 NP_932349.2 Q6PKH6-1D5KJA1
DHRS4L2NM_001193635.1 linkuse as main transcriptc.45-1195C>G intron_variant NP_001180564.1 D5KJA1
DHRS4L2NM_001193636.1 linkuse as main transcriptc.-175-1195C>G intron_variant NP_001180565.1 D5KJA2A0A087WSZ6D5KJA1
DHRS4L2NM_001193637.1 linkuse as main transcriptc.-175-1195C>G intron_variant NP_001180566.1 D5KJA1F6VUV4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DHRS4L2ENST00000335125.11 linkuse as main transcriptc.40C>G p.Arg14Gly missense_variant 1/81 NM_198083.4 ENSP00000334801.6 Q6PKH6-1

Frequencies

GnomAD3 genomes
AF:
0.000263
AC:
40
AN:
151826
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000962
GnomAD3 exomes
AF:
0.0000404
AC:
10
AN:
247648
Hom.:
0
AF XY:
0.0000224
AC XY:
3
AN XY:
134062
show subpopulations
Gnomad AFR exome
AF:
0.000315
Gnomad AMR exome
AF:
0.0000582
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000892
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.0000322
AC:
47
AN:
1459466
Hom.:
2
Cov.:
35
AF XY:
0.0000262
AC XY:
19
AN XY:
725856
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
Gnomad4 AMR exome
AF:
0.000291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000108
Gnomad4 OTH exome
AF:
0.0000995
GnomAD4 genome
AF:
0.000263
AC:
40
AN:
151944
Hom.:
0
Cov.:
33
AF XY:
0.000229
AC XY:
17
AN XY:
74250
show subpopulations
Gnomad4 AFR
AF:
0.000482
Gnomad4 AMR
AF:
0.00111
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000951
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000529
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 28, 2021The c.40C>G (p.R14G) alteration is located in exon 1 (coding exon 1) of the DHRS4L2 gene. This alteration results from a C to G substitution at nucleotide position 40, causing the arginine (R) at amino acid position 14 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
14
DANN
Benign
0.75
DEOGEN2
Benign
0.016
T;T;.;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.18
T;T;.;.;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.019
T;T;T;T;T
MetaSVM
Benign
-0.91
T
PROVEAN
Benign
-0.80
N;N;N;N;N
REVEL
Benign
0.13
Sift
Benign
0.34
T;T;T;T;T
Sift4G
Benign
0.42
T;T;T;T;T
Polyphen
0.0
.;.;.;B;B
Vest4
0.24
MVP
0.23
MPC
0.043
ClinPred
0.0097
T
GERP RS
0.44
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs372560000; hg19: chr14-24458196; API